Feature | Cardiovascular Business | July 17, 2017

SCAI Highlights News from Medicare Trustees Report and 2018 Medicare Physician Fee Schedule

Hospital Outpatient Prospective Payment System proposed rules also released

SCAI comments on CMS payment schedule

July 17, 2017 — The Centers for Medicare and Medicaid Services (CMS) released the 2017 Medicare Trustees Report, the 2018 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment Systems (HOPPS) proposed rules. The Society for Cardiovascular Angiography and Interventions (SCAI) offered the following synopsis of these extensive documents and how the proposals impact on cardiology. 

The Medicare Trustees Report contained good news with an estimated depletion date of 2029 for the trust fund, one year later than last year’s report; believed to be a result of lower inpatient hospital utilization assumptions and lower-than-expected spending in 2016. Also, last year's report prediction that spending levels in 2017 would likely trigger the creation of a cost-cutting, Independent Payment Advisory Board (IPAB) to rein in costs has not come to fruition.

The 2018 MPFS proposed rule revealed an overall update to payments under the MPFS of less than one percent with a proposed $0.10 cent increase to the Medicare conversion factor, raising the conversion factor from $35.89 to $35.99. However, the proposed rule presents an estimated decrease in payments to cardiology of 2 percent for 2018. The estimated 2 percent reduction in cardiology reimbursement is a result of an estimated 1 percent reduction in malpractice values coupled with an estimated 1 percent reduction in practice expense values.

CMS also pushed back the start date for when providers will be required to consult clinical decision support (CDS) for advanced diagnostic imaging (i.e. cardiac CT, cardiac MRI and nuclear perfusion imaging) to 2019.

The 2018 HOPPS proposed rule reflects an anticipated overall impact of 2 percent payment increase to hospitals in 2018 for services paid under HOPPS. The HOPPS proposed rules also reveals CMS' desire to address increasing drug costs by paying separately payable, non pass-through drugs (other than vaccines) purchased at a discount through the 340B drug pricing program at the average sales price (ASP) minus 22.5 percent rather than current ASP plus 6 percent rate.

In addition to the 2018 MPFS and HOPPS proposed rules, CMS issued a Request for Information (RFI) for both, seeking feedback on positive solutions to better achieve transparency, flexibility, program simplification, and innovation. This will inform the discussion on future regulatory action related to outpatient services performed at hospitals and services performed at ambulatory surgical centers related to the MPFS and the HOPPS RFI. 

SCAI advocacy staff and leaders will be reviewing the Medicare Trustees report, the proposed payment rules, and the RFI requests in greater detail and will share pertinent findings and any concerns with members over the coming weeks. 

For more information: www.scai.org


Related Content

News | Cardiovascular Business

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...

Home April 09, 2024
Home
News | Cardiovascular Business

April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit ...

Home April 05, 2024
Home
News | Cardiovascular Business

April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...

Home April 05, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com: 1. CLS Health ...

Home April 04, 2024
Home
News | Cardiovascular Business

March 19, 2024 — The American College of Cardiology (ACC) has selected 50 learners for its 2024 – 2025 Clinical Trials ...

Home March 19, 2024
Home
News | Cardiovascular Business

March 19, 2024 — Titan Medical Inc. announced that it has entered into a definitive amalgamation agreement (the ...

Home March 19, 2024
Home
News | Cardiovascular Business

March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case ...

Home March 15, 2024
Home
News | Cardiovascular Business

March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case ...

Home March 15, 2024
Home
News | Cardiovascular Business

March 13, 2024 — Two nationally recognized cardiovascular programs, New Jersey-based Atlantic Health System’s Morristown ...

Home March 13, 2024
Home
News | Cardiovascular Business

March 11, 2024 — VahatiCor, Inc., a med tech company dedicated to helping patients with persistent ischemic heart ...

Home March 11, 2024
Home
Subscribe Now